Fig. 4.
Nonsteroidal anti-inflammatory drugs (NSAIDs) dosing recommendations are based on CYP2C9 phenotype.20 Of note, CYP2C9 does not have any variants that would make a patient a rapid or ultrarapid metabolizer. This figure was created using Biorender.com.